PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine

Overview of attention for article published in Clinical Cancer Research, June 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 9 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 5 additional patents.